Physician profile
Amy E Miller
NPI 1518545300
$495.13
in general payments reported to CMS, 2019-2025
13 companies · $158 in 2025
The $158 reported for 2025 was less than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $141 · 2022: $99.41 · 2023: $96.41 · 2025: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $255.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $254.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $117.51 | 2021-2025 | Corevalve Evolut R |
| E.R. Squibb & Sons, L.L.C. | $73.24 | 2021-2023 | Camzyos |
| Esperion Therapeutics, INC. | $50.46 | 2021-2025 | Nexletol |
| Boehringer Ingelheim Pharmaceuticals, INC. | $42.63 | 2023 | |
| Pfizer INC. | $40.74 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $35.55 | 2022 | |
| Atricure, INC. | $32.54 | 2022 | |
| Janssen Pharmaceuticals, INC | $25.92 | 2021-2022 | |
| Astellas Pharma US INC | $20.53 | 2021 | |
| Csl Behring | $16.05 | 2023 | Kcentra |
| Amgen INC. | $14.73 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $14.12 | 2021 | |
| Amarin Pharma, INC. | $11.11 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.